GDNF treatment in Parkinson's disease: time for controlled clinical trials?
(2002) In Brain 125(10). p.2149-2151
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/110227
- author
- Brundin, Patrik LU
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Brain
- volume
- 125
- issue
- 10
- pages
- 2149 - 2151
- publisher
- Oxford University Press
- external identifiers
-
- wos:000178613700001
- scopus:0036788442
- ISSN
- 1460-2156
- DOI
- 10.1093/brain/awf217
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Neuronal Survival (013212041)
- id
- 63b40313-d07e-47c4-8bd1-e369d2196e10 (old id 110227)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12244075&dopt=Abstract
- date added to LUP
- 2016-04-01 12:30:09
- date last changed
- 2022-01-27 05:59:44
@article{63b40313-d07e-47c4-8bd1-e369d2196e10,
author = {{Brundin, Patrik}},
issn = {{1460-2156}},
language = {{eng}},
number = {{10}},
pages = {{2149--2151}},
publisher = {{Oxford University Press}},
series = {{Brain}},
title = {{GDNF treatment in Parkinson's disease: time for controlled clinical trials?}},
url = {{http://dx.doi.org/10.1093/brain/awf217}},
doi = {{10.1093/brain/awf217}},
volume = {{125}},
year = {{2002}},
}